The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Transarterial chemoembolization (TACE) does have little impact on hepatic metabolic function in patients with hepatocelluar carcinoma (HCC).
K. Schuette
No relevant relationships to disclose
J. Bornschein
No relevant relationships to disclose
O. Milbradt
No relevant relationships to disclose
K. Mohnike
No relevant relationships to disclose
P. Stuebs
No relevant relationships to disclose
P. Malfertheiner
No relevant relationships to disclose